The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Protein Biomarkers of Cardiovascular Disease and Mortality in the Community
Open accessAbstract
Background: The discovery of novel and highly predictive biomarkers of cardiovascular disease ( CVD ) has the potential to improve risk‐stratification methods and may be informative regarding biological pathways contributing to disease. Methods and Results: We used a discovery proteomic platform that targeted high‐value proteins for CVD to ascertain 85 circulating protein biomarkers in 3523 Framingham Heart Study participants (mean age, 62 years; 53% women). Using multivariable‐adjusted Cox models to account for clinical variables, we found 8 biomarkers associated with incident atherosclerotic CVD , 18 with incident heart failure, 38 with all‐cause mortality, and 35 with CVD death (false discovery rate, q<0.05 for all; P ‐value ranges, 9.8×10 −34 to 3.6×10 −2 ). Notably, a number of regulators of metabolic and adipocyte homeostasis were associated with cardiovascular events, including insulin‐like growth factor 1 ( IGF 1), insulin‐like growth factor binding protein 1 ( IGFBP 1), insulin‐like growth factor binding protein 2 ( IGFBP 2), leptin, and adipsin. In a multimarker approach that accounted for clinical factors, growth differentiation factor 15 ( GDF 15) was associated with all outcomes. In addition, N‐terminal pro‐b‐type natriuretic peptide, C‐reactive protein, and leptin were associated with incident heart failure, and C‐type lectin domain family 3 member B ( CLEC 3B; tetranectin), N‐terminal pro‐b‐type natriuretic peptide, arabinogalactan protein 1 (AGP1), soluble receptor for advanced glycation end products ( sRAGE) , peripheral myelin protein 2 ( PMP 2), uncarboxylated matrix Gla protein ( UCMGP) , kallikrein B1 (KLKB1), IGFBP 2, IGF 1, leptin receptor, and cystatin‐C were associated with all‐cause mortality in a multimarker model. Conclusions: We identified numerous protein biomarkers that predicted cardiovascular outcomes and all‐cause mortality, including biomarkers representing regulators of metabolic homeostasis and inflammatory pathways. Further studies are needed to validate our findings and define clinical utility, with the ultimate goal of improving strategies for CVD prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“sICAM1 is a cell adhesion molecule that previously has been associated with CVD, including myocardial infarction, in case-control studies.(33,34) We now show that sICAM1 predicts not only ASCVD, but also all-cause mortality and CVD mortality.”
BackgroundHeart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692 · cited 1×
“SAA1 is an acute-phase reactant that previously has been associated with future coronary disease in various populations.(38) We report an association of SAA1 with all-cause and CVD mortality.”
BackgroundAN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
Pencina, M. J., & D'Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1802 · Cited by 1,444
Hwang, S.-J., Ballantyne, C. M., Sharrett, A. R., Smith, L. C., Davis, C. E., Gotto, A. M., & Boerwinkle, E. (1997) · Circulation · doi:10.1161/01.cir.96.12.4219 · Cited by 1,344
Self-citationMultiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
Self-citationCystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
Shlipak, M. G., Sarnak, M. J., Katz, R., Fried, L. F., Seliger, S. L., Newman, A. B., Siscovick, D. S., & Stehman-Breen, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043161 · Cited by 1,249
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N. E., Ahfeldt, T., Sachs, K. V., Li, X., Li, H., Kuperwasser, N., Ruda, V. M., et al. (2010) · Nature · doi:10.1038/nature09266 · Cited by 1,140 · cited 1×
“For example, the precursor to GRN is progranulin, and serves as the ligand for sortilin 1 (SORT1),(45) which, in turn, is thought to regulate lipoprotein metabolism and has been linked to risk of myocardial infarction in previous genome-wide association studies studies.(46) We now demonstrate an association of GRN wit…”
ResultSplansky, G. L., Corey, D., Yang, Q., Atwood, L. D., Cupples, L. A., Benjamin, E. J., D'Agostino, R. B., Fox, C. S., Larson, M. G., Murabito, J. M., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm021 · Cited by 860
Self-citationMyeloperoxidase and Cardiovascular Disease
Nicholls, S. J., & Hazen, S. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163262.83456.6d · Cited by 795
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002) · Circulation · doi:10.1161/01.cir.0000027563.44593.cc · Cited by 640
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander, O. (2009) · JAMA · doi:10.1001/jama.2009.943 · Cited by 551
Leptin is a potent stimulator of bone growth in ob/ob mice
Steppan, C. M., Crawford, D. T., Chidsey-Frink, K. L., Ke, H., & Swick, A. G. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00152-x · Cited by 512
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study
Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.129437 · Cited by 482
Statins: new American guidelines for prevention of cardiovascular disease
Ridker, P. M., & Cook, N. R. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62388-0 · Cited by 481
de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., Gibson, C. M., Antman, E. M., McCabe, C. H., Cannon, C. P., & Braunwald, E. (2003) · Circulation · doi:10.1161/01.cir.0000049742.68848.99 · Cited by 469
Parker, B. D., Schurgers, L. J., Brandenburg, V. M., Christenson, R. H., Vermeer, C., Ketteler, M., Shlipak, M. G., Whooley, M. A., & Ix, J. H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00004 · Cited by 457
Meuwese, M. C., Stroes, E. S. G., Hazen, S. L., van Miert, J. N., Kuivenhoven, J. A., Schaub, R. G., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K.-T., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.033 · Cited by 441
Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.
White, R. T., Damm, D., Hancock, N., Rosen, B. S., Lowell, B. B., Usher, P., Flier, J. S., & Spiegelman, B. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50409-4 · Cited by 408
Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay
Carson, R. T., & Vignali, D. A. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00069-1 · Cited by 402
Adipsin Is an Adipokine that Improves β Cell Function in Diabetes
Lo, J. C., Ljubicic, S., Leibiger, B., Kern, M., Leibiger, I. B., Moede, T., Kelly, M. E., Chatterjee Bhowmick, D., Murano, I., Cohen, P., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.005 · Cited by 381
Blankenberg, S., Zeller, T., Saarela, O., Havulinna, A. S., Kee, F., Tunstall-Pedoe, H., Kuulasmaa, K., Yarnell, J., Schnabel, R. B., Wild, P. S., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.901413 · Cited by 367
Ganz, P., Heidecker, B., Hveem, K., Jonasson, C., Kato, S., Segal, M. R., Sterling, D. G., & Williams, S. A. (2016) · JAMA · doi:10.1001/jama.2016.5951 · Cited by 364
duPont, N. C., Wang, K., Wadhwa, P. D., Culhane, J. F., & Nelson, E. L. (2005) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2005.03.005 · Cited by 318
IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance
Wheatcroft, S. B., Kearney, M. T., Shah, A. M., Ezzat, V. A., Miell, J. R., Modo, M., Williams, S. C. R., Cawthorn, W. P., Medina-Gomez, G., Vidal-Puig, A., et al. (2007) · Diabetes · doi:10.2337/db06-0436 · Cited by 267
Resistin, Adiponectin, and Risk of Heart Failure
Frankel, D. S., Vasan, R. S., D'Agostino, R. B., Benjamin, E. J., Levy, D., Wang, T. J., & Meigs, J. B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.073 · Cited by 255
Self-citationMcDermott, D. H., Yang, Q., Kathiresan, S., Cupples, L. A., Massaro, J. M., Keaney, J. F., Larson, M. G., Vasan, R. S., Hirschhorn, J. N., O’Donnell, C. J., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.543579 · Cited by 230
Self-citationNgo, D., Sinha, S., Shen, D., Kuhn, E. W., Keyes, M. J., Shi, X., Benson, M. D., O’Sullivan, J. F., Keshishian, H., Farrell, L. A., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021803 · Cited by 213
Self-citationPlasma Myeloperoxidase Levels in Patients With Chronic Heart Failure
Tang, W. H. W., Brennan, M.-L., Philip, K., Tong, W., Mann, S., Van Lente, F., & Hazen, S. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.04.018 · Cited by 186
Reiner, A. P., Lange, E. M., Jenny, N. S., Chaves, P. H. M., Ellis, J., Li, J., Walston, J. D., Lange, L. A., Cushman, M., & Tracy, R. P. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300421 · Cited by 164
Yin, X., Subramanian, S., Hwang, S., O’Donnell, C. J., Fox, C. S., Courchesne, P. L., Muntendam, P., Gordon, N. F., Adourian, A. S., Juhász, P., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302918 · Cited by 102
Self-citationProgranulin: at the interface of neurodegenerative and metabolic diseases
Nguyen, A. D., Nguyen, T. A., Martens, L. H., Mitic, L. L., & Farese, R. V. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.08.003 · Cited by 95
Foster, M. C., Coresh, J., Hsu, C., Xie, D., Levey, A. S., Nelson, R. G., Eckfeldt, J. H., Vasan, R. S., Kimmel, P. L., Schelling, J. R., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.01.015 · Cited by 94
Lam, C. S. P., Chen, M., Lacey, S. M., Yang, Q., SULLIVAN, L. M., Xanthakis, V., Safa, R., Smith, H., Peng, X., Sawyer, D. B., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.203943 · Cited by 93
Progranulin expression in advanced human atherosclerotic plaque
Kojima, Y., Ono, K., Inoue, K., Takagi, Y., Kikuta, K., Nishimura, M., Yoshida, Y., Nakashima, Y., Matsumae, H., Furukawa, Y., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.017 · Cited by 88
Prentice, R. L., Paczesny, S., Aragaki, A. K., Amon, L. M., Chen, L., Pitteri, S. J., McIntosh, M. W., Wang, P., Busald, T., Hsia, J. A., et al. (2010) · Genome Medicine · doi:10.1186/gm169 · Cited by 84
Novel Filtration Markers as Predictors of All-Cause and Cardiovascular Mortality in US Adults
Foster, M. C., Inker, L. A., Levey, A. S., Selvin, E., Eckfeldt, J. H., Juraschek, S. P., & Coresh, J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.01.016 · Cited by 77
Hu, D., Pawlikowska, L., Kanaya, A. M., Hsueh, W., Colbert, L. H., Newman, A. B., Satterfield, S., Rosen, C. J., Cummings, S. R., Harris, T. B., et al. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02318.x · Cited by 76
Zhang, M. H., Na, B., Schiller, N. B., & Whooley, M. A. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.08.007 · Cited by 55
Soluble Glycoprotein 130 Predicts Fatal Outcomes in Chronic Heart Failure
Askevold, E. T., Nymo, S. H., Ueland, T., Gravning, J. A., Wergeland, R., KJEKSHUS, J. K., Yndestad, A., Cleland, J. G. F., McMurray, J. J. V., Aukrust, P., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.972653 · Cited by 50
Çalan, Ö. G., Çalan, M., Senses, P. Y., Kocabaş, G. Ü., Ozden, E., Sari, K. R., Kocar, M., İmamoğlu, Ç., Senses, Y. M., Bozkaya, G., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13157 · Cited by 50
Nishikido, T., Oyama, J., Shiraki, A., Komoda, H., & Node, K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002863 · Cited by 49
Kaplan, R. C., McGinn, A. P., Pollak, M., Kuller, L. H., Strickler, H. D., Rohan, T. E., Cappola, A. R., Xue, X. N., & Psaty, B. M. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.12.031 · Cited by 33
Orosomucoid: a mortality risk factor in elderly people living in the community?
Raynaud-Simon, A., Lafont, S., Berr, C., Dartigues, J., & Bouc, Y. L. (2002) · Clinical Nutrition · doi:10.1054/clnu.2002.0534 · Cited by 22
Ricketts, S. L., Rensing, K. L., Holly, J. M. P., Chen, L., Young, E. H., Luben, R., Ashford, S. E., Song, K. S., Yuan, X. H., Dehghan, A., et al. (2011) · Europe PMC (PubMed Central) · Cited by 14
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Self-citationHeart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Self-citationHeart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Metadata
- Authors
- Ho, J. E., Lyass, A., Courchesne, P., Chen, G., Liu, C., Yin, X., Hwang, S., Massaro, J. M., Larson, M. G., & Levy, D.
- Venue
- Journal of the American Heart Association
- Published
- 2018-07-17
- Volume
- 7
- Issue
- 14
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2883061610
- Cited by
- 269
- References
- 50
- FWCI
- 20.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.